and 1 1 ± 2 ng/ml, respectively).
Other Coagulation Studies
Blood for coagulation studies was obtained at the end of the 5-mm perfusion from the severed tubing (see above), immediately after obtaining the sample used for obtaining fibrinopeptide A levels (see above).
Clotting and Serum Prothrombin Time
Clotting time ofvenous blood was performed on 3 1-mI samples in glass tubes,2' and serum prothrombin time was determined 1 hr after clotting 2 ml of blood at 37#{176}C2' by adding 0.1 ml of tissue factor-calcium, containing fibrinogen and factor V (Simplastin A, General Diagnostics, Morris Plains, Ni) to 0.1 ml of serum. the post-chamber FPA levels (3 subjects tested) were 55 ± 1 I ng/ml.
Preparation ofPlatelet-Rich and

Platelet-Poor Plasma
The FPA levels after 10-mm exposure in normal subjects were 700 ± 65 ng/ml. FPA levels were markedly reduced after 5-and 10-mm exposure times in patients with factor VIII deficiency (102 ± 19 and 69 ± 13) and factor IX deficiency (61 ± 14 and 61 ± 9). Higher values (but still less than normal) were obtained in patients deficient in factor XI (135 ± 20 and 189 ± 61) and factor XII (291 ± 82 and 163 ± 14). A small amount of FPA (7 and 25 ng/ml) was obtained in the patient with fibrinogen deficiency. FPA levels were normal in the 2 patients with factor VII deficiency (573 and 885 at 5 mm; 41 1 and 997 at 10 mm).
Platelet Thrombus Dimensions
The volume and average height of the three tallest platelet thrombi on the subendothelium after exposure of the vessel segments to blood for 5 and 10 mm were measured on the same vessel cross-sections that were used to measure fibrin deposition. The values obtained for normal subjects and coagulation-deficient patients are shown in 
